SRTA

Strata Critical Medical, Inc. Industrials Transportation Services Russell 3000
$4.44Close $385.0MMarket cap $4.03 – $6.4752-week range Nov 3, 2026Next report · before the open

Highlights

Cautions

  • Not in an uptrend 1 of 8 trend conditions
  • Lagging the market RS 20 · weaker than 80% of stocks over 12 months
  • Far from its high 31% below its 52-week high
  • Results soon Nov 3, 2026, in 2 days

Price

Filing Results Screen pick 52-week high and low Adjusted prices

Key figures

FY to Dec 31, 2025 · filed Aug 4, 2026
Off 12-month high 31%
1wk down 4.7% price change
1mo down 13.1% price change
12-month return down 13% market up 11% · its own down 23%
F-score 5 / 9 Mixed
Altman Z″ 6.54 Low risk
P/E 9.3× price / earnings
PEG — P/E / EPS growth
P/B 1.4× price / book
Earnings yield down 6.3% EBIT / enterprise value
Cheaper than 33% of the market · expensive
Revenue growth up 34% year on year
EPS growth — latest quarter
Sales growth up 61% latest quarter · -27 pts
ROE up 17% return on equity
Free cash margin down 30% -$58.5M FCF
D/E — long-term debt / equity
Net debt / EBITDA —
Interest cover —EBIT / interest
Piotroski tests
  • operating cash flow is negative
  • profits not fully backed by cash
  • short-term liquidity weakened
  • issued more shares
  • profitable on its assets
  • profitability improving
  • reduced long-term debt
  • gross margin widened
  • assets working harder

Repair signals

  • Revenue reaccelerating (-35% then +34%)

Trade setup

ATR% 4.3% $0.19 a day · 2×ATR $4.06
RS 20 / 99 vs the universe
Trend 1 / 8 trend template
Relative volume 1.3× vs 50-day average
Up/down volume 0.69 50 sessions
Implied move — no option chain · report Nov 3, 2026
Trend template · 1 of 8
  • 150-day average above the 200-day: passes

Screen verdict

Did not qualify for any screen.

Warning signs

2 flagged
  • Shareholders diluted The share count rose 9.2% over the year, from 79m to 87m shares. Each existing share owns a smaller fraction of the company than it did a year ago.
  • Profit not backed by cash Reported profit of $41.3M came with -$48.9M of operating cash flow. Profit that cash does not follow is the classic signature of aggressive accounting.
Last reported Aug 4, 2026
Results reaction Aug 4, 2026+4% vs market2 sessions after results

Financials

6 fiscal years · from filings
Revenue What customers paid the company over its fiscal year, before any cost, as filed in its annual report. The change is against the year before. Methodology $197.1M +34% on FY2024
$0 $250M FY20 FY21 FY22 FY23 FY24 FY25 FY2020 FY2021 · $50.5M FY2022 · $146.1M FY2023 · $225.2M FY2024 · $146.8M FY2025 · $197.1M
Net income Profit left after every cost, interest and tax for the year. A column below the line is a loss. Methodology $41.3M back to a profit
-$100M $0 $50M FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · -$20.5M FY2021 · -$40.1M FY2022 · -$27.3M FY2023 · -$56.1M FY2024 · -$27.3M FY2025 · $41.3M
Free cash flow Cash from running the business less what it spent on equipment and buildings: the cash a year actually left behind, which profit alone does not show. Not shown for banks and insurers, whose cash moves with their loans. Methodology -$58.5M
-$100M $0 FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · -$794,467 FY2021 · -$15.9M FY2022 · -$37.9M FY2023 · -$34.5M FY2024 · -$33.4M FY2025 · -$58.5M
Margins Each as a share of revenue. Gross: left after the direct cost of what was sold. Net: left after every cost. Free cash: free cash flow over revenue. A margin rising over years means the business keeps more of each dollar it sells. Methodology
  • Gross 21%
  • Net 21%
  • Free cash -30%
-100% 0% 25% FY20 FY21 FY22 FY23 FY24 FY25 FY2020 FY2021 · Gross 21% · Net -79% · Free cash -31% FY2022 · Gross 15% · Net -19% · Free cash -26% FY2023 · Gross 19% · Net -25% · Free cash -15% FY2024 · Gross 20% · Net -19% · Free cash -23% FY2025 · Gross 21% · Net 21% · Free cash -30%
Cash and long-term debt Cash on the balance sheet at the year's end beside debt due after a year. Net cash is cash less that debt; net debt is the shortfall. Debt some filers do not tag shows as a gap, not as zero. Methodology
  • Cash
  • Long-term debt
$0 $50M FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · Cash $10.2M FY2021 · Cash $7.0M FY2022 · Cash $41.3M · Long-term debt $0 FY2023 · Cash $27.9M FY2024 · Cash $18.4M FY2025 · Cash $31.0M
Shares outstanding Shares in issue at the year's end. A rising count means each share owns a smaller slice of the company (stock pay, share sales); a falling one, buybacks. The chart's scale is fitted to the count, so a small change looks large: read the percentage. Methodology 86.70m
86.70m 70.10m FY20 FY21 FY22 FY23 FY24 FY25 FY2020 FY2021 · 70.10m FY2022 · 71.66m FY2023 · 75.13m FY2024 · 79.42m FY2025 · 86.70m
  FY2020Dec 31, 2020 FY2021Sep 30, 2021 FY2022Dec 31, 2022 FY2023Dec 31, 2023 FY2024Dec 31, 2024 FY2025Dec 31, 2025
Revenue — $50.5M $146.1M $225.2M $146.8M $197.1M
Gross margin — 21% 15% 19% 20% 21%
Operating income -$678,487 -$24.1M -$53.5M -$68.1M -$22.5M -$22.4M
Net income -$20.5M -$40.1M -$27.3M -$56.1M -$27.3M $41.3M
Net margin — -79% -19% -25% -19% 21%
Earnings per share — -$0.93 -$0.38 -$0.76 -$0.35 $0.50
Free cash flow -$794,467 -$15.9M -$37.9M -$34.5M -$33.4M -$58.5M
Free cash margin — -31% -26% -15% -23% -30%
Cash $10.2M $7.0M $41.3M $27.9M $18.4M $31.0M
Long-term debt — — $0 — — —
Shareholders' equity $10.0M $291.2M $274.5M $234.3M $221.9M $279.1M
Shares outstanding — 70.10m 71.66m 75.13m 79.42m 86.70m

Filings

SEC EDGAR
FiledReportPeriod to Lag
Aug 4, 2026 Quarterly ↗ Jun 30, 2026 35d
May 6, 2026 Quarterly ↗ Mar 31, 2026 36d
Mar 3, 2026 Annual ↗ Dec 31, 2025 62d
Nov 10, 2025 Quarterly ↗ Sep 30, 2025 41d
Aug 5, 2025 Quarterly ↗ Jun 30, 2025 36d
May 12, 2025 Quarterly ↗ Mar 31, 2025 42d
Mar 13, 2025 Annual ↗ Dec 31, 2024 72d
Nov 12, 2024 Quarterly ↗ Sep 30, 2024 43d
Aug 8, 2024 Quarterly ↗ Jun 30, 2024 39d
May 7, 2024 Quarterly ↗ Mar 31, 2024 37d
Mar 12, 2024 Annual ↗ Dec 31, 2023 72d
Nov 8, 2023 Quarterly ↗ Sep 30, 2023 39d

Current reports